|
1
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fuchs Y and Steller H: Live to die another
way: Modes of programmed cell death and the signals emanating from
dying cells. Nat Rev Mol Cell Biol. 16:329–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fuchs Y and Steller H: Programmed cell
death in animal development and disease. Cell. 147:742–758. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ryoo HD, Gorenc T and Steller H: Apoptotic
cells can induce compensatory cell proliferation through the JNK
and the Wingless signaling pathways. Dev Cell. 7:491–501. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamaguchi Y and Miura M: Programmed cell
death in neurodevelopment. Dev Cell. 32:478–490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buss RR, Gould TW, Ma J, Vinsant S,
Prevette D, Winseck A, Toops KA, Hammarback JA, Smith TL and
Oppenheim RW: Neuromuscular development in the absence of
programmed cell death: Phenotypic alteration of motoneurons and
muscle. J Neurosci. 26:13413–13427. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ferrer I, Soriano E, del Rio JA, Alcántara
S and Auladell C: Cell death and removal in the cerebral cortex
during development. Prog Neurobiol. 39:1–43. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuan CY, Flavell RA and Rakic P:
Programmed cell death in mouse brain development. Results Probl
Cell Differ. 30:145–162. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haydar TF, Nowakowski RS, Yarowsky PJ and
Krueger BK: Role of founder cell deficit and delayed neuronogenesis
in microencephaly of the trisomy 16 mouse. J Neurosci.
20:4156–4164. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yeo W and Gautier J: Early neural cell
death: Dying to become neurons. Dev Biol. 274:233–244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de la Rosa EJ and de Pablo F: Cell death
in early neural development: Beyond the neurotrophic theory. Trends
Neurosci. 23:454–458. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oppenheim RW: Cell death during
development of the nervous system. Annu Rev Neurosci. 14:453–501.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Verney C, Takahashi T, Bhide PG,
Nowakowski RS and Caviness VS Jr: Independent controls for
neocortical neuron production and histogenetic cell death. Dev
Neurosci. 22:125–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Favaloro B, Allocati N, Graziano V, Di
Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging
(Albany NY). 4:330–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamblin MR: Photobiomodulation for
traumatic brain injury and stroke. J Neurosci Res. 96:731–743.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sureda A, Capó X and Tejada S:
Neuroprotective effects of flavonoid compounds on neuronal death
associated to Alzheimer's disease. Curr Med Chem. 26:5124–5136.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gitler AD, Dhillon P and Shorter J:
Neurodegenerative disease: Models, mechanisms, and a new hope. Dis
Model Mech. 10:499–502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Egawa N, Lok J, Washida K and Arai K:
Mechanisms of axonal damage and repair after central nervous system
injury. Transl Stroke Res. 8:14–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li C, Wang D, Wu W, Yang W, Ali Shah SZ,
Zhao Y, Duan Y, Wang L, Zhou X, Zhao D and Yang L: DLP1-dependent
mitochondrial fragmentation and redistribution mediate
prion-associated mitochondrial dysfunction and neuronal death.
Aging Cell. 17:e126932018. View Article : Google Scholar
|
|
21
|
Kischkel FC, Lawrence DA, Chuntharapai A,
Schow P, Kim KJ and Ashkenazi A: Apo2L/TRAIL-dependent recruitment
of endogenous FADD and caspase-8 to death receptors 4 and 5.
Immunity. 12:611–620. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sharma D and Kanneganti TD: Inflammatory
cell death in intestinal pathologies. Immunol Rev. 280:57–73. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bleicken S, Landeta O, Landajuela A,
Basañez G and García-Sáez AJ: Proapoptotic Bax and Bak proteins
form stable protein-permeable pores of tunable size. J Biol Chem.
288:33241–33252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu L, Zhang R, Liu K, Zhou H, Tang Y, Su
J, Yu X, Yang X, Tang M and Dong Q: Tissue kallikrein alleviates
glutamate-induced neurotoxicity by activating ERK1. J Neurosci Res.
87:3576–3590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sheikh MS and Huang Y: Death receptor
activation complexes: It takes two to activate TNF receptor 1. Cell
Cycle. 2:550–552. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bourteele S, Oesterle K, Weinzierl AO,
Paxian S, Riemann M, Schmid RM and Planz O: Alteration of NF-kappaB
activity leads to mitochondrial apoptosis after infection with
pathological prion protein. Cell Microbiol. 9:2202–2217. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fiegen D, Blumenstein L, Stege P, Vetter
IR and Ahmadian MR: Crystal structure of Rnd3/RhoE: Functional
implications. FEBS Lett. 525:100–104. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jie W, Andrade KC, Lin X, Yang X, Yue X
and Chang J: Pathophysiological functions of Rnd3/RhoE. Compr
Physiol. 6:169–186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J
and Settleman J: Identification of a novel human Rho protein with
unusual properties: GTPase deficiency and in vivo farnesylation.
Mol Cell Biol. 16:2689–2699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Riento K, Guasch RM, Garg R, Jin B and
Ridley AJ: RhoE binds to ROCK I and inhibits downstream signaling.
Mol Cell Biol. 23:4219–4229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Klein RM and Aplin AE: Rnd3 regulation of
the actin cytoskeleton promotes melanoma migration and invasive
outgrowth in three dimensions. Cancer Res. 69:2224–2233. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pacary E, Azzarelli R and Guillemot F:
Rnd3 coordinates early steps of cortical neurogenesis through
actin-dependent and -independent mechanisms. Nat Commun.
4:16352013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin X, Liu B, Yang X, Yue X, Diao L, Wang
J and Chang J: Genetic deletion of Rnd3 results in aqueductal
stenosis leading to hydrocephalus through up-regulation of Notch
signaling. Proc Natl Acad Sci USA. 110:8236–8241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang X, Wang T, Lin X, Yue X, Wang Q, Wang
G, Fu Q, Ai X, Chiang DY, Miyake CY, et al: Genetic deletion of
Rnd3/RhoE results in mouse heart calcium leakage through
upregulation of protein kinase A signaling. Circ Res. 116:e1–e10.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sheng Y, Song Y, Li Z, Wang Y, Lin H,
Cheng H and Zhou R: RAB37 interacts directly with ATG5 and promotes
autophagosome formation via regulating ATG5-12-16 complex assembly.
Cell Death Differ. 25:918–934. 2018.PubMed/NCBI
|
|
36
|
Yuan J, Zhang Y, Sheng Y, Fu X, Cheng H
and Zhou R: MYBL2 guides autophagy suppressor VDAC2 in the
developing ovary to inhibit autophagy through a complex of
VDAC2-BECN1-BCL2L1 in mammals. Autophagy. 11:1081–1098. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu B, Dong H, Lin X, Yang X, Yue X, Yang
J, Li Y, Wu L, Zhu X, Zhang S, et al: RND3 promotes Snail 1 protein
degradation and inhibits glioblastoma cell migration and invasion.
Oncotarget. 7:82411–82423. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun Q, Dong H, Li Y, Yuan F, Xu Y, Mao S,
Xiong X, Chen Q and Liu B: Small GTPase RHOE/RND3, a new critical
regulator of NF-κB signalling in glioblastoma multiforme? Cell
Prolif. 52:e126652019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu B, Guo Z, Dong H, Daofeng T, Cai Q, Ji
B, Zhang S, Wu L, Wang J, Wang L, et al: LRIG1, human EGFR
inhibitor, reverses multidrug resistance through modulation of
ABCB1 and ABCG2. Brain Res. 1611:93–100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG; NC3Rs Reporting Guidelines Working Group, : Animal
research: Reporting in vivo experiments: The ARRIVE guidelines. Br
J Pharmacol. 160:1577–1579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brockman JA, Scherer DC, McKinsey TA, Hall
SM, Qi X, Lee WY and Ballard DW: Coupling of a signal response
domain in I kappa B alpha to multiple pathways for NF-kappa B
activation. Mol Cell Biol. 15:2809–2818. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen ZJ, Parent L and Maniatis T:
Site-specific phosphorylation of IkappaBalpha by a novel
ubiquitination-dependent protein kinase activity. Cell. 84:853–862.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Waldmeier PC and Tatton WG: Interrupting
apoptosis in neurodegenerative disease: Potential for effective
therapy? Drug Discov Today. 9:210–218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Briggs R, Kennelly SP and O'Neill D: Drug
treatments in Alzheimer's disease. Clin Med (Lond). 16:247–253.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pacary E, Heng J, Azzarelli R, Riou P,
Castro D, Lebel-Potter M, Parras C, Bell DM, Ridley AJ, Parsons M
and Guillemot F: Proneural transcription factors regulate different
steps of cortical neuron migration through Rnd-mediated inhibition
of RhoA signaling. Neuron. 69:1069–1084. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mocholí E, Ballester-Lurbe B, Arqué G,
Poch E, Peris B, Guerri C, Dierssen M, Guasch RM, Terrado J and
Pérez-Roger I: RhoE deficiency produces postnatal lethality,
profound motor deficits and neurodevelopmental delay in mice. PLoS
One. 6:e192362011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dai Y, Song J, Li W, Yang T, Yue X, Lin X,
Yang X, Luo W, Guo J, Wang X, et al: RhoE fine-tunes inflammatory
response in myocardial infarction. Circulation. 139:1185–1198.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ongusaha PP, Kim HG, Boswell SA, Ridley
AJ, Der CJ, Dotto GP, Kim YB, Aaronson SA and Lee SW: RhoE is a
pro-survival p53 target gene that inhibits ROCK I-mediated
apoptosis in response to genotoxic stress. Curr Biol. 16:2466–2472.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhu Y, Zhou J, Xia H, Chen X, Qiu M, Huang
J, Liu S, Tang Q, Lang N, Liu Z, et al: The Rho GTPase RhoE is a
p53-regulated candidate tumor suppressor in cancer cells. Int J
Oncol. 44:896–904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yue X, Yang X, Lin X, Yang T, Yi X, Dai Y,
Guo J, Li T, Shi J, Wei L, et al: Rnd3 haploinsufficient mice are
predisposed to hemodynamic stress and develop apoptotic
cardiomyopathy with heart failure. Cell Death Dis. 5:e12842014.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gutierrez H and Davies AM: Regulation of
neural process growth, elaboration and structural plasticity by
NF-κB. Trends Neurosci. 34:316–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mémet S: NF-kappaB functions in the
nervous system: From development to disease. Biochem Pharmacol.
72:1180–1195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Qin ZH, Tao LY and Chen X: Dual roles of
NF-κB in cell survival and implications of NF-kappaB inhibitors in
neuroprotective therapy. Acta Pharmacol Sin. 28:1859–1872. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mo SJ, Hong J, Chen X, Han F, Ni Y, Zheng
Y, Liu JQ, Xu L, Li Q, Yang XH, et al: VEGF-mediated NF-κB
activation protects PC12 cells from damage induced by hypoxia.
Neurosci Lett. 610:54–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen S, Jiang S, Zheng W, Tu B, Liu S,
Ruan H and Fan C: RelA/p65 inhibition prevents tendon adhesion by
modulating inflammation, cell proliferation, and apoptosis. Cell
Death Dis. 8:e27102017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Murshed F, Farhana L, Dawson MI and
Fontana JA: NF-κB p65 recruited SHP regulates PDCD5-mediated
apoptosis in cancer cells. Apoptosis. 19:506–517. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sirotkin AV, Dekanová P, Harrath AH,
Alwasel SH and Vašíček D: Interrelationships between sirtuin 1 and
transcription factors p53 and NF-κB (p50/p65) in the control of
ovarian cell apoptosis and proliferation. Cell Tissue Res.
358:627–632. 2014. View Article : Google Scholar : PubMed/NCBI
|
